A Study of JZP541 in Adults With Irritability Associated With Autism Spectrum Disorder

Summary

Behavior dysregulation is commonly associated with people with autism spectrum disorder (ASD). Irritability is a major safety concern in adults with ASD. This study will assess the efficacy and safety of JZP541 in the treatment of adults with irritability associated with ASD.

Timeline

Start

2023-06-30

Primary completion

2023-11-09

Completion

2023-11-09

Outcome

Outcome not reported

Stopped: “A decision has been made to prioritize other pipeline programs and terminate this study.”

Drugs

Indications